National Stroke Foundation

Lamictal (lamotrigine) Chewable Dispersible Tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved June 1999

Specific Treatments:


Therapeutic Areas

General Information

The approval of these efficacy supplements provide for the use of Lamictal as conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing antiepileptic drug.